| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |